Scientific Articles

Ejlertsen, B. et al.

583P Validation of a cisplatin response predictor in carboplatin-treated metastatic breast cancer patients

Annals of Oncology, Volume 36, September 2025

Nielsen, D. et al.

Predictive biomarker for cisplatin in prospective phase 2 of liposomal cisplatin in metastatic breast cancer

Journal of Clinical Oncology, May 2023

Kappel Buhl, I. et al.

A Drug Response Predictor to Guide Treatment for Breast Cancer

Taylor and Francis, 2019

Kappel Buhl, I. et al.

Molecular prediction of adjuvant cisplatin efficacy in Non-Small Cell Lung Cancer (NSCLC)—validation in two independent cohorts

PloS One, 2018; 10.1371

Hugger Jacobsen, E et. al.

Liposomal cisplatin response prediction in heavily pretreated breast cancer patients: A multigene biomarker in a prospective phase 2 study

Journal of Clinical Oncology, 2018, e13077

Vangsted, A.J. et al.

Drug response prediction in high-risk multiple myelomas

National Library of Medicine, 2018

Kappel Buhl, I. et. al.

Prospective blinded evaluation predicting efficacy of adjuvant cisplatinum and vinorelbine by a multigene assay after radical surgery in non-small cell lung cancer

Abstract no.: e20007, ASCO Annual Meeting, Chicago, 2016

Lassen et. al.

Abstract CT154: Phase I dose-escalating PoC study to evaluate the safety and tolerability of LiPlaCis (liposomal cisplatin formulation) in patients with advanced or refractory tumor

Cancer Research 76 (14 supplement), July 2016